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Abstract 
The paper evaluated the efficiency of a standard cleaning procedure of the process equipment after production of anti-
hypertensive with the active component Losartan Potassium for different lengths of time between completion of 
production and the start of the treatment process – so called dirty-hold time. It has been found that the cleaning 
process is appropriately designed and efficient. The concentration of losartan in swabs from the equipments was in all 
cases within the limits of acceptance criteria. However, the washing process was in all cases sufficiently effective to 
meet the eligibility criteria, significant effect of the time of weaning of the contaminated equipment on the efficiency 
of the washing process was found. At studied dirty hold time horizon (0-4 days) there was a progressive deterioration 
of the efficiency of the cleaning process. It was found that the influence of the nature of the residual material on the 
cleaning process has minor effect then the length of the dirty hold time. Laboratory experiments provide comparable 
results for both wet and dry contamination of the surface. 
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1. Introduction 
Qualification of the cleaning process is carried out using methods of a visual control of cleanliness [1], 
a wet-swab sampling and analysis of controlled substances [2], an analysis of the last rinse water or final 
rinse media, an analytical evaluation of subsequently produced placebo and a microbiological assay of the 
last rinse water [3]. The API (active pharmaceutical ingredient), an excipient or the detergent are the 
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controlled substances. For a single production line or the production device one product representing all 
products manufactured on this line can be determined based on a method of "worst case" [4]. The criteria 
for selecting the worst case are a complexity of the cleaning process, a solubility in a cleaning media, the 
greatest toxicity, the lowest therapeutic dose and the lowest limit (eg from the therapeutic dose). Sampling 
is usually performed after a maximum number of produced batches. Process qualifications of the washing 
procedure are carried out for newly manufactured products, a new equipment, new systems CIP (Clean in 
Place) and recently used detergents [1].  
Typically, the washing process in the pharmaceutical plant begins immediately after the production 
batch. The postponement of several days can make more efficient use of working time and lead to cost 
reductions, but the residuals of the produced material, however, may become more difficult removable 
after the delay [5]. Dirty-hold time is part of the cleaning validation process from the beginning, but often 
overlooked [6]. 
The work was aimed on the cleaning process efficiency and the cleanliness of the pharmaceutical 
apparatuses after the end of the production and subsequent cleaning process. Influence of the dirty-hold 
time, e.g. the time interval between the end of the production period and beginning of the cleaning process 
on the cleanliness of the equipment was studied.  
2. Experimental 
2.1. Materials and equipment 
The formulation with active substance Losartan potassium has been studied. Losartan potassium is a 
white crystalline powder well soluble in water and alcohols and slightly soluble in common organic 
solvents. 
Commercial product also contains excipients: microcrystalline cellulose, mannitol, sodium salt of 
croscarmellose, povidone, magnesium stearate, hypromellose 2910/5, macrogol 6000, talc, simethicone 
emulsion, coating system opaspray M-1-22801. Based on the worst case method active substance 
(Losartan potassium) was selected as the studied substance with the acceptance criterion of 312 Pg/dm2. 
Swab was performed using cotton coil weighing from 80 to 150 mg in the tweezers wetted with 0.5 ml 
of methanol. Swab material was extracted prior to use in a Soxhlet extractor with methanol for 3 hours, so 
that there were no contaminants. Sampling area was 100 cm2 and the dimensions were commonly 10x10 
cm. A marked area was wiped in one direction and then in another, perpendicular to the first, swab was 
usually rotated. Closed sample container with the wet cotton swab was weighed on an analytical balance. 
Then 1 ml of methanol-water solution (3:1 vol.) was added and treated at least 15 minutes. After an 
extraction and a centrifugation the proportion of liquid is transferred to the sample vials, which are used 
for HPLC analysis. 
Model experiments were performed in a pharmaceutical company Zentiva a.s. on identical production 
lines A and B containing the following equipments: granulator Fielder and fluid dryer Aeromatic. After 
washing and drying processes, swabs from both devices were taken with a cotton swab wetted with 
methanol. Total number of 11 samples, their description and location of sampling places are listed in 
Tab.1. 
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Table 1. Sampling places of the taken swabs 
Equipment Sampling place Sample name 
Granulator 
Fielder  
Lid G1 
Wall G2 
Bottom near the outlet G3 
Stirrer paddle G4 
Rear side of the outlet G5 
Area near the hopper G6 
Fluid dryer Aeromatic 
F5 
Wall S1 
Cone wall S2 
Sieve S3 
Cone wall (2nd sample) S4 
Sieve (2nd sample)  S5 
 
Laboratory experiments were performed on the sheets made from stainless steel (AISI 316L) 
simulating surface of the pharmaceutical devices. Losartan was deposited on the sheet from the dry 
granulate prepared in Zentiva a.s. by a) spraying a concentrated solution in water, b) coating from a paste. 
Samples were therefore left to dry on air at room temperature. Before wet swabs being taken, the sheets 
were cleaned using procedure simulating cleaning process. It consists of rinsing with water, cleaning with 
commercial detergent, rinsing with water and subsequent rinsing with deionised water. 
Samples analyses were carried out using HPLC Shimadzu Prominence LC20 by the method in Tab. 2. 
Losartan concentrations were calculated according to performed calibration dependence. The active 
substance losartan was detected at a wavelength of 254 nm. The detection limit is given by the medium-
term fluctuations of the baseline signal from the baseline noise value the detection limit of 0.1 Pg was 
determined. The quantification limit was determined as triple the detection limit of 0.3 Pg. 
Table 2. HPLC method parameters 
Column LichroSpher RP Select B 
Mobile phase CH3OH, H2O, 0.5M H3PO4 in ratio 40:10:0,5 
Mobile phase flow rate 0.8 ml min 1 
Thermostat column temperature 30 °C 
Sample volume 20 Pl 
 
A typical record of chromatographic analysis is shown in Fig. 1. Losartan elutes under the chosen 
conditions at the time of 3.57 min and is separated from the remaining substances contained in the swabs 
from the manufacturing equipment. 
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Fig. 1. Chromatogram of G3 wet-swab analysis from production line A 
3. Results and Discussion 
The effect of a time interval between the end of the production period of the device and its cleaning i.e. 
the dirty-hold time has been studied in 3-level case study. Samples were taken using the above mentioned 
technique from equipment after standard production of one batch of the product, after the dirty-hold time 
period of 0, 2 or 4 days, and subsequent standard cleaning operation. In case of 0 days dirty-hold time, the 
cleaning was performed immediately after the end of production. 
Table 3. Detected amount of losartan in the swabs from production lines (μg/dm2) 
Sample 
identification 
Production line 
A B A A 
4 days 2 days 0 days 
S1 0.8 1.1 0 0.0 
S2 20.8 4.2 1.4 0.0 
S3 5.0 1.0 0.6 0.0 
S4 30.9 0.7 2.4 0.0 
S5 4.6 2.4 0.8 0.0 
G1 0.8 1.0 0.9 0.0 
G2 1.3 4.3 0.5 0.0 
G3 38.0 1.4 1.1 2.1 
G4 8.0 2.0 5.4 0.0 
G5 4.0 0.9 0.8 0.0 
G6 4.5 15.7 1.8 0.0 
blank 0.0 - 0.0 0.0 
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Tab. 3 contains values obtained from the analyses of the swabs taken from the studied devices. The 
highest values of losartan content were detected on sampling places at the bottom near the outlet of 
granulator Fielder (G3) and the cone wall of Aeromatic fluid dryer (S4) at the production line A, where 
the dirty-hold time was 4 days. At the production line B the highest value was found on the sampling 
place: area near the hopper of granulator Fielder (G6). None of the measured values exceeded the 
acceptance criterion. 
For the dirty-hold time 2 days the highest values of losartan content were detected on the sampling 
places on cone wall (2nd sample) of fluid dryer Aeromatic (S4), and stirrer paddle of granulator Fielder 
(G4). All the detected values were about one order lower than the values at 4 days dirty-hold time and in 
all cases the acceptance criterion was met. The only non-zero value of losartan content in the swabs taken 
from devices immediately cleaned after production was detected on the sampling place at bottom near the 
outlet of granulator Fielder (G3). 
Although from the production line B only one series of samples was obtained, while from the 
production line A three series of samples were obtained, it was possible for both lines to compare the 
values of contamination extension on the individual sampling places, because it is the same device. As the 
most critical places can be regarded the sampling places on the cone wall of Aeromatic fluid dryer and at 
the bottom near the outlet of Fielder granulator, where higher concentrations of losartan were repeatedly 
detected in the swabs. 
Against expectations it was found that the effect of the dirty-hold time was similar both for the device, 
in which wet residue of product typically remain after the hold-time (granulator) and for the device where 
this is not usual (fluid dryer).  
Laboratory tests with dry and wet contamination on sheets that simulate a surface of the 
pharmaceutical equipment were carried out to determine the influence of the nature of contaminant. Even 
if the used laboratory sheets represent only easy cleaned areas, the contamination with losartan was found 
when the cleaning process was not started immediately after the deposition of the model contamination. 
Values in Tab. 4 are mean from 6 samples each from the different sheet.  
Table 4. Detected amount of losartan in the swabs from laboratory contaminated sheets (μg/dm2) 
Impurity 
preparation 4 days 2 days 0 days 
Solution 4.9 2.3 0.0 
Dry paste 5.8 2.9 0.0 
 
Similar to the experiments on pharmaceutical equipments, dirty-hold time on the laboratory sheet has 
the influence on the cleaning process efficiency. Concentration of losartan in the wet swabs taken from 
the sheets is increasing with the time delay between contamination and cleaning. Only minor differences 
between two experimentally tested procedures of the deposition of losartan were observed. It was found 
that cleaning the sheets coated with dry paste was less effective, but concentration of losartan found by 
the analysis of the wet swab was far below the acceptance limit. 
4. Conclusions 
It was found that even if the washing process was in all cases sufficiently effective to meet the 
eligibility criteria, the time of weaning of the contaminated equipment has significant effect on the 
efficiency of the washing process. At studied dirty-hold time horizon (0-4 days) there was a progressive 
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deterioration of the efficiency of a treatment. It was found that the effect of dirty-hold time is similar in 
the equipments, in which typically after the withdrawal of the product remains moist (granulator) and in 
facilities where this does not occur (drier). It was found that the influence of the nature of the contaminant 
has minor effect then the delay between the end of the production and the cleaning process. 
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